home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

FDA Requirements for Device Labeling: Development, Contents, Distribution, and Changes

 
  August 13, 2013  
     
 
ComplianceOnline, Online Event
2013-08-23


Why You Should Attend:

Your  company's marketing department wants to entice customers to buy your product instead of your competitor's! A common method is to make the labeling as eye-catching as possible. Be careful! You need to know what information can (and more importantly) CANNOT be present on the labeling. Sometimes mislabeling and aggressive labeling can put you in to trouble.

This FDA labeling webinar will provide a comprehensive knowledge of labeling development and subsequent control. The updated FDA requirements and expectations regarding labeling contents will be covered. We will discuss the recommended best practices  and how to follow it to assure substantial compliance. This presentation provides comprehensive knowledge of labeling development and subsequent control. FDA requirements and expectations regarding labeling contents will be covered, as will recommended practices to assure compliance.

Areas Covered in the seminar:

  • Prescription Device Labeling.
  • Misbranding, False Or Misleading Labeling.
  • Approval.
  • Issuance.
  • Label Integrity.
  • Label Inspection.
  • Contractor-Produced Labels As A Linkage With Purchasing Controls.
  • Retention.
  • When a labeling change requires a new submission
 
 
Organized by: ComplianceOnline
Invited Speakers: Jeff Kasoff, RAC, is the Director of Regulatory Affairs at Life-Tech, Inc., a leading manufacturer of consumables and instrumentation in the urodynamic and pain management fields. Jeff is responsible for oversight of corporate compliance with domestic and international regulations, preparation of submissions, and is primary liaison with regulatory agencies and notified bodies. Jeff began his regulatory career as the first full-time employee of Optex Biomedical, a device start-up, where he initiated their regulatory policies and procedures and prepared their submissions. Jeff received his Regulatory Affairs Certification in 1996.
 
Deadline for Abstracts: 2013-08-23
 
Registration: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=701143?channel=hummolgen
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.